Transcatheter aortic valve replacement as effective as surgery in intermediate patients
Saturday, March 18, 2017 - 17:01
in Health & Medicine
Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial.